Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Andoh

Showing results (341-350 of 363) with videos related to

Pageof 37
Sort By:
The American Journal of Gastroenterology|September 3, 2009
An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatmentAtsushi Sakuraba, Satoshi Motoya, Kenji Watanabe, et al.
Intestinal Research|May 11, 2018
Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countriesTaku Kobayashi, Tadakazu Hisamatsu, Yasuo Suzuki, et al.
Journal of Gastroenterology and Hepatology|July 17, 2020
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in AsiaZhihua Ran, Kaichun Wu, Katsuyoshi Matsuoka, et al.
Gastroenterology|November 28, 2017
Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative ColitisMakoto Naganuma, Shinya Sugimoto, Keiichi Mitsuyama, et al.
Intestinal Research|February 10, 2018
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: managementDong Il Park, Tadakazu Hisamatsu, Minhu Chen, et al.
Intestinal Research|February 10, 2018
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessmentDong Il Park, Tadakazu Hisamatsu, Minhu Chen, et al.
Gut|August 21, 2016
Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitisAtsushi Masamune, Isao Nishimori, Kazuhiro Kikuta, et al.
Journal of Crohn'S & Colitis|November 9, 2021
Crohn's Disease and Early Exposure to Thiopurines are Independent Risk Factors for Mosaic Chromosomal Alterations in Patients with Inflammatory Bowel DiseasesYoichi Kakuta, Hideya Iwaki, Junji Umeno, et al.
Journal of Gastroenterology and Hepatology|October 13, 2017
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: ManagementDong Il Park, Tadakazu Hisamatsu, Minhu Chen, et al.
Journal of Gastroenterology and Hepatology|October 13, 2017
Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessmentDong Ii Park, Tadakazu Hisamatsu, Minhu Chen, et al.
Pageof 37

Showing results (341-350 of 363) with videos related to

Sort By:
Pageof 37
The American Journal of Gastroenterology|September 3, 2009
An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatmentAtsushi Sakuraba, Satoshi Motoya, Kenji Watanabe, et al.
Intestinal Research|May 11, 2018
Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countriesTaku Kobayashi, Tadakazu Hisamatsu, Yasuo Suzuki, et al.
Journal of Gastroenterology and Hepatology|July 17, 2020
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in AsiaZhihua Ran, Kaichun Wu, Katsuyoshi Matsuoka, et al.
Gastroenterology|November 28, 2017
Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative ColitisMakoto Naganuma, Shinya Sugimoto, Keiichi Mitsuyama, et al.
Intestinal Research|February 10, 2018
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: managementDong Il Park, Tadakazu Hisamatsu, Minhu Chen, et al.
Intestinal Research|February 10, 2018
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessmentDong Il Park, Tadakazu Hisamatsu, Minhu Chen, et al.
Gut|August 21, 2016
Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitisAtsushi Masamune, Isao Nishimori, Kazuhiro Kikuta, et al.
Journal of Crohn'S & Colitis|November 9, 2021
Crohn's Disease and Early Exposure to Thiopurines are Independent Risk Factors for Mosaic Chromosomal Alterations in Patients with Inflammatory Bowel DiseasesYoichi Kakuta, Hideya Iwaki, Junji Umeno, et al.
Journal of Gastroenterology and Hepatology|October 13, 2017
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: ManagementDong Il Park, Tadakazu Hisamatsu, Minhu Chen, et al.
Journal of Gastroenterology and Hepatology|October 13, 2017
Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessmentDong Ii Park, Tadakazu Hisamatsu, Minhu Chen, et al.
Pageof 37